A diagnostic challenge: Life-threatening drug reaction with eosinophilia and systemic symptoms in the setting of a SARS-CoV-2 and human herpesvirus-6 reactivation in a patient with severe hepatic injury on bupropion
Saved in:
Main Authors: | Djoni Elkady, BS (Author), Chiamaka L. Okorie, BS (Author), Blanca Estupiñan, MD (Author), Mitul B. Modi, MD (Author), Scott J. Cotler, MD (Author), Eden Lake, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful management with ganciclovir of drug reaction with eosinophilia and systemic symptoms secondary to antituberculous drugs associated to human herpesvirus-6 reactivation
by: Eduardo Corona-Rodarte, MD, et al.
Published: (2023) -
Alectinib-associated drug reaction with eosinophilia and systemic symptoms syndrome
by: Sahira Farooq, BS, et al.
Published: (2020) -
Apremilast-associated drug reaction with eosinophilia and systemic symptoms
by: Stephanie Chapman, MS, MD, et al.
Published: (2020) -
A case of drug reaction with eosinophilia and systemic symptoms with colitis as a presenting feature
by: Payal Shah, BS, et al.
Published: (2021) -
Plasmacytoid dendritic cells diminution in peripheral blood is prevalent in drug reaction with eosinophilia and systemic symptoms and may precede human herpesvirus 6 reactivation
by: Shao-Hsuan Hsu, et al.
Published: (2021)